The only big loser this week was JLP:Jubilee Metals, which is a big surprise given how much more their products are worth. I expected these to be doing much better under the circumstances.
OPTI:Optibiotix clawed back 3p of the 10p lost last week, which is 5%, of my purchase price, but they are the main reason things are so bad at the moment.
PLUS:Plus500 also climbed 5% and are now only 13% down and should be
doing very well with the current market volatility.
TLOU:Tlou Energy are making lots of positive noises about not being
far from earning revenue. The share price went up 6% but is still way, way
below what it was when revenue was a long way off.
FXPO:Ferrexpo recovered 7% as presumably investors are hoping they are far enough away from the main cities to escape any serious damage. I wouldn't bet on it though, and I certainly wouldn't be buying them.
CMCL:Caledonia Mining has so far failed to budge as the gold price
has increased, but this week climbed 10%. They are still 18% down which
says a lot about how bad my timing was when I bought them.
DDDD:4D Pharma may be on the cusp of recovery as their forced
seller may have finished selling. If that's the case then the shorters
will close and there should be a good bounce. This week they recovered 10%
but are still 68% down.
Share of the Week is SBTX:SkinBioTherapeutics which had a late
rally and went up 12%, with my SIPP holding going back into profit.
It looks a depressingly small recovery, but it's a start.
Way below the trend line and will be for a while I suspect
Here's the ISA and shares portfolio after week 32 of year 7.
JLP:Jubilee Metals is the only share in profit and that dropped £60. Long term profit/dividend performance still good.
| Weekly Change | |||
| Cash | £25.80 |
+£0 | |
| Portfolio cost | £72,195.21 | +£0 | |
| Portfolio sell value (bid price-commission) | £35,406.98 | (-51.0%) | +£3,511.76 |
| Potential profits | £2,155.29 | -£60.00 | |
| Yr 7 Dividends | £22.16 | +£0 | |
| Yr 7 Profit from sales | £3,664.29 | +£0 | |
| Yr 7 projected avg monthly profit | £495.65 | (13.4%) | -£15.99 |
| Total Dividends | £1,365.31 | +£0 | |
| Total Profit from sales | £27,788.23 | +£0 | |
| Average monthly cash profit |
£363.37 |
(9.9%) | -£1.06 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 65% | +0% |
JLP:Jubilee Metals is the only share in profit and that dropped £60. Long term profit/dividend performance still good.
Same story as combined chart
Bad, but not as bad as last week
The SIPP looks like this after week 328 overall and week 16 of year 7.
My monthly saving was invested in iShares Physical Gold before I had a chance to switch it to something cheaper, and that's making £66 potential profit now, along with the £64 from SBTX:SkinBioTherapeutics going back into the black. Long term performance needs a boost but I don't know where it's going to come from.
I keep adding more money but it keeps going down.
A whole year following the trend line downwards and still below it.
| Weekly Change | ||||
| Cash | £100.45 | +£10.88 | ||
| Portfolio cost | £84,005.89 | +£119.12 | ||
|
Portfolio sell value (bid price - commission) |
£44,052.97 | (-47.6%) | +£4,296.39 | |
| Potential profits | £130.51 | +£77.55 | ||
| Yr 7 Dividends | £96.57 | +£0 | ||
| Yr 7 Interest | £0 | +£0 | ||
| Yr 7 Profit from sales | £526.22 | +£0 | ||
| Yr 7 projected avg monthly profit | £150.81 | (3.5%) | -£10.06 | |
| Total Dividends | £3,300.96 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £24,250.85 | +£0 | ||
| Average monthly cash profit | £352.27 | (8.1%) | -£1.07 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 51% | +0% |
My monthly saving was invested in iShares Physical Gold before I had a chance to switch it to something cheaper, and that's making £66 potential profit now, along with the £64 from SBTX:SkinBioTherapeutics going back into the black. Long term performance needs a boost but I don't know where it's going to come from.
I keep adding more money but it keeps going down.
A whole year following the trend line downwards and still below it.
The trading account looks like this after week 294 overall and week 34 of year 6.
Good bounce back this week mainly thanks to DDDD:4D Pharma. The Nasdaq share LBPS was up 34% by the end of trading so hopefully we will catch up on Monday.
| Weekly Change | |||
| Cash | £259.74 | +£0 | |
| Portfolio cost | £2,374.14 | +£0 | |
| Portfolio sell value (bid price - commission) | £813.71 | (-65.7%) | +£90.02 |
| Potential profits | £0.00 | +£0 | |
| Year 6 Dividends | £0.00 | +£0 | |
| Year 6 Profit | £0.00 | +£0 | |
| Yr 6 projected avg monthly profit | £0.00 | (0%) | +£0 |
| Dividends | £60.10 | +£0 | |
| Profit from sales | £937.88 | +£0 | |
| Average monthly cash profit | £14.71 | (7.4%) | -£0.05 |
|
(Sold stocks profit + Dividends - Fees / Months) |
Good bounce back this week mainly thanks to DDDD:4D Pharma. The Nasdaq share LBPS was up 34% by the end of trading so hopefully we will catch up on Monday.
I'm slightly less depressed than I was last week, but things are still
looking fairly bleak. Some good news next week will help rather a lot.
No comments:
Post a Comment